The TXB4-TrkB fusion antibody crossed the BBB, accumulated in the brain, and triggered neurotrophin signaling in target cells susceptible to loss in AD (cortical neurons) and PD (dopaminergic neurons in the SNc). The gene discussed is NTRK2; the disease is Alzheimer disease.